Although Syneron Medical Ltd. (ELOS) is up over 16.15% in the past four weeks, investors may be concerned. After all, ELOS is now in overbought territory, at least when looking at its RSI value of 70.2. If that wasn’t enough, investors should also note that Syneron Medical Ltd. possesses a Zacks Rank #5 (strong Sell), so if analyst perception is any guide, we could witness a slump in ELOS shares before too long.
SYNERON MEDICAL LTD ORD (ELOS): Free Stock Analysis Report
Zacks Investment Research
- Health Care Industry